Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. Congress

Congress

2023216

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's Next Generation Cardiovascular Drug Development in April 25-27.

2023216

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in May 2-4.

2022630

Congress Keiichi Fukuda, CEO at Heartseed is speaking at this year's Cell & Gene Therapy World Asia Summit in September 15-16.

2022614

Congress Takehiko Kaneko, CMO at Heartseed, is speaking at this year's webinar by American Physiological Society.

2022614

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in July 26-28.

2021622

Congress Kikuo Yasui, COO speaks at the International Society for Stem Cell Research (ISSCR) 2021, "Driving Change in Regenerative Medicine Through Global Partnerships: Organized by Novo Nordisk Stem Cell R&D"

2021615

Congress Keiichi Fukuda, CEO gave a presentation titled "Clinical Application of Human iPS Cell-Derived Ventricular Cardiomyocytes for Heart Failure Treatment" at Deep Tech in Asia: Stem Cell Innovations by SGInnovate.

1

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
The Artcomplex Center of Tokyo #302, 12-9, Daikyo-cho, Shinjuku-ku, Tokyo 160-0015, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • Contacts

language

  • English
  • Japanese
  • GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED